| scholarly article | Q13442814 |
| P50 | author | Dingxiao Zhang | Q42247868 |
| P2093 | author name string | Dean G Tang | |
| John DiGiovanni | |||
| Mark Badeaux | |||
| John R Moore | |||
| Mahipal V Suraneni | |||
| Donna Kusewitt | |||
| Marc D Macaluso | |||
| P2860 | cites work | Differential characteristics of human 15-lipoxygenase isozymes and a novel splice variant of 15S-lipoxygenase | Q22010728 |
| Identification of amino acid determinants of the positional specificity of mouse 8S-lipoxygenase and human 15S-lipoxygenase-2 | Q22011034 | ||
| Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells | Q24292284 | ||
| Subcellular Localization and Tumor-suppressive Functions of 15-Lipoxygenase 2 (15-LOX2) and Its Splice Variants | Q24300188 | ||
| Discovery of a second 15S-lipoxygenase in humans | Q24336768 | ||
| The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 | Q24617130 | ||
| Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis | Q24681977 | ||
| Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells | Q28202104 | ||
| Truncating mutations of RB1CC1 in human breast cancer | Q28204953 | ||
| c-MYC: more than just a matter of life and death | Q28205057 | ||
| RB1CC1 suppresses cell cycle progression through RB1 expression in human neoplastic cells | Q28208056 | ||
| Neuromuscular abundance of RB1CC1 contributes to the non-proliferating enlarged cell phenotype through both RB1 maintenance and TSC1 degradation | Q28253890 | ||
| Molecular cloning and functional expression of a phorbol ester-inducible 8S-lipoxygenase from mouse skin | Q28510563 | ||
| Integrative genomic profiling of human prostate cancer | Q29619905 | ||
| Integrative molecular concept modeling of prostate cancer progression. | Q33266777 | ||
| RB1CC1 activates RB1 pathway and inhibits proliferation and cologenic survival in human cancer | Q33627736 | ||
| 15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma | Q33867006 | ||
| Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. | Q34014956 | ||
| Downregulation of vascular endothelial growth factor and induction of tumor dormancy by 15-lipoxygenase-2 in prostate cancer | Q34033679 | ||
| Evidence that Sp1 positively and Sp3 negatively regulate and androgen does not directly regulate functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) gene expression in normal human prostate epithelial cells | Q34332767 | ||
| Lipoxygenase modulation to reverse carcinogenesis. | Q34346656 | ||
| 15-lipoxygenase 2 (15-LOX2) is a functional tumor suppressor that regulates human prostate epithelial cell differentiation, senescence, and growth (size). | Q34590246 | ||
| Effect of 15-lipoxygenase metabolites, 15-(S)-HPETE and 15-(S)-HETE on chronic myelogenous leukemia cell line K-562: reactive oxygen species (ROS) mediate caspase-dependent apoptosis | Q34630569 | ||
| Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis | Q35207795 | ||
| Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. | Q35693712 | ||
| FIP200, a key signaling node to coordinately regulate various cellular processes | Q36515638 | ||
| Prostate cancer stem/progenitor cells: identification, characterization, and implications. | Q36572143 | ||
| In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals | Q37344789 | ||
| The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. | Q39540612 | ||
| RB1CC1 activates the p16 promoter through the interaction with hSNF5. | Q39743172 | ||
| Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells. | Q39956460 | ||
| RB1CC1 activates the promoter and expression of RB1 in human cancer. | Q39980189 | ||
| Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells | Q40291759 | ||
| Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. | Q40731052 | ||
| Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma | Q42440649 | ||
| Transgenic expression of 15-lipoxygenase 2 (15-LOX2) in mouse prostate leads to hyperplasia and cell senescence | Q42472293 | ||
| Cell-autonomous induction of functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) contributes to replicative senescence of human prostate progenitor cells | Q42475181 | ||
| A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo | Q42496913 | ||
| Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases | Q44521056 | ||
| Myc-driven murine prostate cancer shares molecular features with human prostate tumors | Q45049671 | ||
| Evidence that senescent human prostate epithelial cells enhance tumorigenicity: cell fusion as a potential mechanism and inhibition by p16INK4a and hTERT. | Q53326362 | ||
| Immortalization of primary human prostate epithelial cells by c-Myc. | Q53359625 | ||
| LRIG1 and the liar paradox in prostate cancer: A study of the expression and clinical significance of LRIG1 in prostate cancer | Q60651155 | ||
| Role of hydroperoxyeicosatetraenoic acids in oxidative stress-induced activating protein 1 (AP-1) activity | Q71763053 | ||
| Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia | Q73028655 | ||
| Nuclear volume estimates in prostatic atypical adenomatous hyperplasia | Q73369390 | ||
| Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion | Q77847672 | ||
| P433 | issue | 11 | |
| P921 | main subject | prostate cancer | Q181257 |
| P1104 | number of pages | 13 | |
| P304 | page(s) | 1798-1810 | |
| P577 | publication date | 2014-04-14 | |
| P1433 | published in | Cell Cycle | Q1254166 |
| P1476 | title | Tumor-suppressive functions of 15-Lipoxygenase-2 and RB1CC1 in prostate cancer | |
| P478 | volume | 13 |
| Q38838622 | Antineoplastic effects of 15(S)-hydroxyeicosatetraenoic acid and 13-S-hydroxyoctadecadienoic acid in non-small cell lung cancer. |
| Q49334906 | Comparison of the expression of TGF-β1, E-cadherin, N-cadherin, TP53, RB1CC1 and HIF-1α in oral squamous cell carcinoma and lymph node metastases of humans and mice |
| Q39104480 | Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase Pathway. |
| Q48226915 | Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System. |
| Q40134213 | Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts. |
| Q40757101 | Involvement of 15-lipoxygenase-1 in the regulation of breast cancer cell death induced by sodium butyrate |
| Q92105279 | Regulation and Functions of 15-Lipoxygenases in Human Macrophages |
| Q42626453 | Strict Regiospecificity of Human Epithelial 15-Lipoxygenase-2 Delineates Its Transcellular Synthesis Potential |
| Q49231491 | Transcriptomic features of primary prostate cancer and their prognostic relevance to castration-resistant prostate cancer |
| Q42750079 | Tumor-suppressing 15-lipoxygenase-2: time for prime time? |
| Q91750471 | Up-regulation of 15-lipoxygenase enzymes and products in functional and non-functional pituitary adenomas |
Search more.